Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery

Cardiovascular Research

Volumn 61, Issue 4, 2004, Pages 683-692

  Kawabata, Atsufumi ^a   Kubo, Satoko ^a   Nakaya, Yumiko ^a   Ishiki, Tsuyoshi ^a   Kuroda, Ryotaro ^a   Sekiguchi, Fumiko ^a   Kawao, Naoyuki ^a   Nishikawa, Hiroyuki ^b  

^a KINKI UNIVERSITY   (Japan)

^b Fuso Pharmaceutical Industries Ltd   (Japan)

Author keywords

Arteries; Nitric oxide; Proteases; Receptors; Vasoconstriction dilation

Indexed keywords

17 OCTADECYNOIC ACID; APAMIN; CARBENOXOLONE; CATALASE; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OUABAIN; PEPTIDE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; SCAVENGER; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINAMIDE; THREONYLPHENYLALANYLLEUCYLLEUCYLARGININAMIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GAP JUNCTION; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SUPERIOR MESENTERIC ARTERY; VASCULAR RING; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA; INDOMETHACIN; MALE; MESENTERIC ARTERY, SUPERIOR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDES; RATS; RATS, WISTAR; RECEPTOR, PAR-1; RECEPTOR, PAR-2; TRYPSIN; VASODILATION;

EID: 1342345222     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2003.11.030     Document Type: Article

References (47)

1. Macfarlane S.R., Seatter M.J., Kanke T., Hunter G.D., Plevin R. Proteinase-activated receptors. Pharmacol. Rev. 53:2001;245-282.
2. Vu T.K., Hung D.T., Wheaton V.I., Coughlin S.R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
3. Xu W.F., Andersen H., Whitmore T.E., et al. Cloning and characterization of human protease-activated receptor 4. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6642-6646.
4. Ishihara H., Connolly A.J., Zeng D., et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 386(6624):1997;502-506.
5. Kahn M.L., Zheng Y.W., Huang W., et al. A dual thrombin receptor system for platelet activation. Nature. 394:1998;690-694.
6. Nystedt S., Emilsson K., Wahlestedt C., Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci. U. S. A. 91:1994;9208-9212.
7. Kawabata A. Multiple roles for protease-activated receptor-2 in gastric mucosa. Inflammopharmacology. 10:2003;343-349.
8. Kawao N., Sakaguchi Y., Tagome A., et al. Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion. Br. J. Pharmacol. 135:2002;1292-1296.
9. Kawabata A. Gastrointestinal functions of proteinase-activated receptors. Life Sci. 74:2003;247-254.
10. Kawabata A., Kinoshita M., Nishikawa H., et al. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J. Clin. Invest. 107:2001;1443-1450.
11. Cocks T.M., Fong B., Chow J.M., et al. A protective role for protease-activated receptors in the airways. Nature. 398:1999;156-160.
12. Cocks T.M., Moffatt J.D. Protease-activated receptor-2 (PAR2) in the airways. Pulm. Pharmacol. Ther. 14:2001;183-191.
13. Kawabata A., Kawao N., Kuroda R., Tanaka A., Shimada C. The PAR-1-activating peptide attenuates carrageenan-induced hyperalgesia in rats. Peptides. 23:2002;1181-1183.
14. Kawabata A., Kawao N., Kuroda R., Tanaka A., Itoh H., Nishikawa H. Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats. NeuroReport. 12:2001;715-719.
15. Vergnolle N., Bunnett N.W., Sharkey K.A., et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. 7:2001;821-826.
16. Cicala C. Protease activated receptor 2 and the cardiovascular system. Br. J. Pharmacol. 135:2002;14-20.
17. Cicala C., Morello S., Santagada V., Caliendo G., Sorrentino L., Cirino G. Pharmacological dissection of vascular effects caused by activation of protease-activated receptors 1 and 2 in anesthetized rats. FASEB J. 15:2001;1433-1435.
18. Damiano B.P., Cheung W.M., Santulli R.J., et al. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther. 288:1999;671-678.
19. Kawabata A., Nakaya Y., Kuroda R., et al. Involvement of EDHF in the hypotension and increased gastric mucosal blood flow caused by PAR-2 activation in rats. Br. J. Pharmacol. 140:2003;247-254.
20. Laniyonu A.A., Hollenberg M.D. Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta. Br. J. Pharmacol. 114:1995;1680-1686.
21. Saifeddine M., al-Ani B., Cheng C.H., Wang L., Hollenberg M.D. Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br. J. Pharmacol. 118:1996;521-530.
22. Hollenberg M.D., Saifeddine M., al-Ani B., Kawabata A. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can. J. Physiol. Pharmacol. 75:1997;832-841.
23. Sobey C.G., Moffatt J.D., Cocks T.M. Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. Stroke. 30:1999;1933-1940.
24. Hamilton J.R., Cocks T.M. Heterogeneous mechanisms of endothelium-dependent relaxation for thrombin and peptide activators of protease-activated receptor-1 in porcine isolated coronary artery. Br. J. Pharmacol. 130:2000;181-188.
25. Hamilton J.R., Nguyen P.B., Cocks T.M. Atypical protease-activated receptor mediates endothelium-dependent relaxation of human coronary arteries. Circ. Res. 82:1998;1306-1311.
26. McLean P.G., Aston D., Sarkar D., Ahluwalia A. Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ. Res. 90:2002;465-472.
27. Gui Y., Loutzenhiser R., Hollenberg M.D. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am. J. Physiol. Renal. Physiol. 285:2003;F95-F104.
28. McGuire J.J., Hollenberg M.D., Andrade-Gordon P., Triggle C.R. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. Br. J. Pharmacol. 135:2002;155-169.
29. Fernandez-Patron C., Radomski M.W., Davidge S.T. Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. Am. J. Physiol. Heart Circ. Physiol. 278:2000;H1473-H1479.
30. Kawabata A., Kuroda R., Nakaya Y., Kawai K., Nishikawa H., Kawao N. Factor Xa-evoked relaxation in rat aorta: involvement of PAR-2. Biochem. Biophys. Res. Commun. 282:2001;432-435.
31. Edwards G., Weston A.H. EDHF - are there gaps in the pathway? J. Physiol. 531:2001;299.
32. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature. 396:1998;269-272.
33. Fisslthaler B., Popp R., Kiss L., et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 401:1999;493-497.
34. Fukao M., Hattori Y., Kanno M., Sakuma I., Kitabatake A. Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery. Br. J. Pharmacol. 120:1997;439-446.
35. Matoba T., Shimokawa H., Nakashima M., et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J. Clin. Invest. 106:2000;1521-1530.
36. Matoba T., Shimokawa H., Kubota H., et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem. Biophys. Res. Commun. 290:2002;909-913.
37. Taylor H.J., Chaytor A.T., Evans W.H., Griffith T.M. Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-alpha glycyrrhetinic acid. Br. J. Pharmacol. 125:1998;1-3.
38. Edwards G., Feletou M., Gardener M.J., Thollon C., Vanhoutte P.M., Weston A.H. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br. J. Pharmacol. 128:1999;1788-1794.
39. Goto K., Fujii K., Kansui Y., Abe I., Iida M. Critical role of gap junctions in endothelium-dependent hyperpolarization in rat mesenteric arteries. Clin. Exp. Pharmacol. Physiol. 29:2002;595-602.
40. Brandes R.P., Schmitz-Winnenthal F.H., Feletou M., et al. An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc. Natl. Acad. Sci. U. S. A. 97:2000;9747-9752.
41. Van de Voorde J., Vanheel B. EDHF-mediated relaxation in rat gastric small arteries: influence of ouabain/Ba2+ and relation to potassium ions. J. Cardiovasc. Pharmacol. 35:2000;543-548.
42. Doughty J.M., Boyle J.P., Langton P.D. Potassium does not mimic EDHF in rat mesenteric arteries. Br. J. Pharmacol. 130:2000;1174-1182.
43. Hollenberg M.D., Yang S.G., Laniyonu A.A., Moore G.J., Saifeddine M. Action of thrombin receptor polypeptide in gastric smooth muscle: identification of a core pentapeptide retaining full thrombin-mimetic intrinsic activity. Mol. Pharmacol. 42:1992;186-191.
44. Hollenberg M.D., Laniyonu A.A., Saifeddine M., Moore G.J. Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes. Mol. Pharmacol. 43:1993;921-930.
45. Holland J.A., Meyer J.W., Chang M.M., O'Donnell R.W., Johnson D.K., Ziegler L.M. Thrombin stimulated reactive oxygen species production in cultured human endothelial cells. Endothelium. 6:1998;113-121.
46. David-Dufilho M., Brunet A., Privat C., Devynck M.A. Analysis of agonist-evoked nitric oxide release from human endothelial cells: role of superoxide anion. Clin. Exp. Pharmacol. Physiol. 28:2001;1015-1019.
47. Kawabata A, Nishikawa H, Saitoh H. et al. A protective role of protease-activated receptor-1 in rat gastric mucosa. Gastroenterology; in press.